You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Made-in-India Covid vaccines more cost-effective than others in world: PM

Prime Minister Narendra Modi on Monday said the two already approved made-in-India COVID-19 vaccines are more cost-effective than any other in the world

Topics
Coronavirus Tests | Coronavirus Vaccine | Narendra Modi

Press Trust of India  |  New Delhi 

narendra modi
Prime Minister Narendra Modi

Prime Minister on Monday said the two already approved made-in-India COVID-19 vaccines are more cost-effective than any other in the world and have been developed as per the country's needs.

Interacting with chief ministers of all states to discuss the COVID-19 situation and the vaccination roll-out in the country, Modi also said that apart from the two already approved vaccines, four others are in the pipeline.

"Our experts have taken all precautions to provide the countrymen with effective vaccines," he said.

The two approved COVID-19 vaccines in India more cost-effective than other vaccines in the world and have been developed as per our needs and situation, he said.

India is entering a decisive phase of vaccination in the fight against COVID-19, he asserted, pointing that the world's largest vaccination programme will start from January 16.

Public representatives are not part of the three-crore corona warriors and frontline workers to be vaccinated first, Modi said.

In the first phase, the cost of vaccination for these 3 crore people would be borne by the central government, he added.

India's drugs regulator has approved Oxford vaccine Covishield, being manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country.

On Saturday last week, Modi had reviewed the status of COVID-19 and vaccine preparedness across states and union territories at a high-level meeting where.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, January 11 2021. 17:46 IST
RECOMMENDED FOR YOU